Company to Review Registration Strategy for XYOTAX(TM) and ASCO Presentations
SEATTLE, June 7 /PRNewswire-FirstCall/ -- On Wednesday, June 7, 2006, at 4:30 p.m. Eastern/1:30 p.m. Pacific, members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq: CTIC; MTAX) management team will host a conference call to discuss the recent announcements regarding the registration strategy for XYOTAX(TM) (paclitaxel poliglumex) in the United States and Europe and to review data presented at the American Society of Clinical Oncology (ASCO) meeting.
Conference Call Wednesday, June 7 4:30 p.m. Eastern/1:30 p.m. Pacific 1-888-603-9073 (US Participants) 1-210-234-0011 (International) Entry code: CTIC
Call-back numbers for post listening 1-800-964-4665 (US) 1-203-369-3695 (International) Entry code: CTIC
Live audio webcast at www.cticseattle.com
Will be archived for post listening approximately two hours after call ends
Source: Cell Therapeutics, Inc.
